Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.06B |
| Enterprise Value | 13.22B |
| P/E Ratio | -34.89 |
| PEG Ratio | 101.08 |
| Price/Sales Ratio | 8.09 |
| Price/Book Ratio | 25.03 |
| Enterprise/Revenue | 8.14 |
| Enterprise/EBITDA | -35.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0.25 |
| Return On Assets | -0.26 |
| Return On Equity | -0.57 |
| Revenue | 958.4M |
| Revenue/Share | 44.05 |
| Gross Profit | 902.26M |
| EBITDA | -264.47M |
| Net Income | -288.28M |
| Diluted EPS | -12.85 |
| Total Cash | 838.75M |
| Total Cash/Share | 28.78 |
| Total Debt | 347.75M |
| Total Debt/Equity | 0.66 |
| Current Ratio | 3.2 |
| Book Value Per Share | 17.97 |
| 52-Week Change | 2.47 |
| 52-Week High | 615 |
| 52-Week Low | 393.61 |
| Moving Average 50 Days | 514.44 |
| Moving Average 200 Days | 505.11 |
| Average Volume | 292,387 |
| Shares Outstanding | 23.1M |
| % Held by Institutions | 81.57 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | July 25, 2016 |